Evidence map›Paper›PMID 39995204›Full record

ReviewFEBS letters2025

Unraveling Mycobacterium tuberculosis acid resistance and pH homeostasis mechanisms.

Janïs Laudouze, Stéphane Canaan, Alexandre Gouzy, Pierre Santucci

Abstract readReview
In one paragraph

Review in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Peptide-Based Strategies AgainstPharmaceuticals (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Janïs LaudouzeAix Marseille Univ, CNRS, LISM, IMM, Marseille, France.
Stéphane CanaanAix Marseille Univ, CNRS, LISM, IMM, Marseille, France.ORCID https://orcid.org/0000-0001-7478-300X
Alexandre GouzyDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, USA.
Pierre SantucciAix Marseille Univ, CNRS, LISM, IMM, Marseille, France.ORCID https://orcid.org/0000-0002-6291-3425

Funding

Determination of the mode of action of the antibiotic pyrazinamideR21AI168673 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GOUZY, ALEXANDRE · 2023 to 2024
$466k
Agence Nationale de la Recherche ANR-24-CE15-2633Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS) ANRS0358Aix-Marseille UniversitéCentre National de la Recherche ScientifiqueFEBS Excellence AwardInitiative d'Excellence d'Aix-Marseille Université - A*MIDEX AMX-19-IET-006Ministère de l'Enseignement Supérieur et de la RechercheNIAID NIH HHS R21 AI168673NIH HHS R21 AI168673
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) is a successful pathogen that has developed a variety of strategies to survive and replicate within host cells. Among them, resistance mechanisms that allow Mtb to cope with the acidic environment of the endolysosomal network play a crucial role in its host adaptation and pathogenesis. In this Review, we summarize our understanding regarding the molecular factors contributing to Mtb acid resistance and the maintenance of intrabacterial pH homeostasis within in vitro and in cellulo systems. We also discuss some of the recently emerged concepts regarding host adaptation to acid stress, with a special emphasis on central carbon metabolism. Finally, we introduce some of the current and future direction(s) in this fast-evolving field of research.

Indexed as

AcidsHomeostasisMycobacterium tuberculosisTuberculosisAnimalsHumansHydrogen-Ion ConcentrationAcidsacid–base equilibriumbuffering capacitiesendolysosomesprotonsvirulence factors

Identifiers

PMID39995204
PMCPMC12183614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.